Solana Co — Director's Dealing 2016

Aug 9, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2016-08-08

Reporting Person: GRIFFIN THOMAS E (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$1	2020-08-08	Class A Common Stock (100000)		Direct

Footnotes

F1: 1/4 of total options vested on date of grant; 1/4 will vest on first anniversary of date of grant; 1/2 will vest on second anniversary of date of grant.

F2: Translated into US dollars from Canadian dollars based on closing exchange rate from the Bank of Canada. USD $1.00=CAD $1.31 on August 8, 2016; based on exercise price of CAD $1.31.